Hepatitis A vaccine: Indirect evidence of immune memory 12 years after the primary course

被引:39
作者
Van Herck, K [1 ]
Van Damme, P
Lievens, M
Stoffel, M
机构
[1] Univ Antwerp, WHO, Collaborating Ctr Prevent & Control Viral Hepatit, Ctr Evaluat Vaccinat, B-2020 Antwerp, Belgium
[2] GlaxoSmithKline Biol, Rixensart, Belgium
关键词
long-term protection; adults; hepatitis A vaccine; immune memory; anamnestic response;
D O I
10.1002/jmv.10574
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vaccine-induced hepatitis A antibodies persist up to 10 years in adults, with mathematical models estimating further persistence up to 20-25 years. Thirty-one adults received booster inoculations 12 years after their initial vaccination (Havrix(TM) 720 EI.U at months 0, 1, 6). At the time of booster inoculation, all still had detectable antibodies. All but one subject met pre-defined criteria for anamnestic response 14 days after the booster, and all subjects did so after 30 days. The subjects' geometric mean titre (GMT) increased rapidly from 242 IU/L at baseline to 3,832 IU/L at day 14 and 5,282 IU/L at day 30. This study shows a substantial immune response to re-exposure to hepatitis A antigen after 12 years, which occurs rapidly to ensure protection within the average incubation period of hepatitis A virus. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:194 / 196
页数:3
相关论文
共 9 条
[1]  
Andre Francis, 2002, Expert Rev Vaccines, V1, P9, DOI 10.1586/14760584.1.1.9
[2]   Hepatitis A vaccine [J].
Bell, BP .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (12) :1187-1188
[3]   Immunization against hepatitis A in the first year of life: Priming despite the presence of maternal antibody [J].
Dagan, R ;
Amir, J ;
Mijalovsky, A ;
Kalmanovitch, I ;
Bar-Yochai, A ;
Thoelen, S ;
Safary, A ;
Ashkenazi, S .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (11) :1045-1052
[4]   DEPRESSION OF THE IMMUNE-RESPONSE TO AN INACTIVATED HEPATITIS-A VACCINE ADMINISTERED CONCOMITANTLY WITH IMMUNE GLOBULIN [J].
GREEN, MS ;
COHEN, D ;
LERMAN, Y ;
SJOGREN, M ;
BINN, LN ;
ZUR, S ;
SLEPON, R ;
ROBIN, G ;
HOKE, C ;
BANCROFT, W ;
SAFARY, A ;
DANON, Y ;
WIENER, M .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (03) :740-743
[5]   Hepatitis A booster vaccination: is there a need? [J].
Van Damme, P ;
Banatvala, J ;
Fay, O ;
Iwarson, S ;
McMahon, B ;
Van Herck, K ;
Shouval, D ;
Bonanni, P ;
Connor, B ;
Cooksley, G ;
Leroux-Roels, G ;
Von Sonnenburg, F .
LANCET, 2003, 362 (9389) :1065-1071
[6]   INACTIVATED HEPATITIS-A VACCINE - REACTOGENICITY, IMMUNOGENICITY, AND LONG-TERM ANTIBODY PERSISTENCE [J].
VANDAMME, P ;
THOELEN, S ;
CRAMM, M ;
DEGROOTE, K ;
SAFARY, A ;
MEHEUS, A .
JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (04) :446-451
[7]  
VANHERCK K, 2002, VIRAL HEPATITIS LIVE, P56
[8]  
VANHERCK K, 2002, P 10 INT C INF DIS I, P183
[9]   HEPATITIS-A ANTIBODY-TITERS AFTER INFECTION AND IMMUNIZATION - IMPLICATIONS FOR PASSIVE AND ACTIVE IMMUNIZATION [J].
ZAAIJER, HL ;
LEENTVAARKUIJPERS, A ;
ROTMAN, H ;
LELIE, PN .
JOURNAL OF MEDICAL VIROLOGY, 1993, 40 (01) :22-27